中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2008年
9期
21-23
,共3页
体外受精-胚胎移植%异位妊娠
體外受精-胚胎移植%異位妊娠
체외수정-배태이식%이위임신
In vitro fertilization and embryo transfer%Ectopic pregnancy
目的 探讨体外受精-胚胎移植后异位妊娠的发生率、高危因素及诊断、预防.方法对我院2005年3月至2007年12月接受体外受精-胚胎移植(包括卵胞浆内单精子显微注射)治疗后的970个移植周期的临床资料进行回顾性分析.结果 329例获临床妊娠,其中宫内妊娠303例,异位妊娠26例(包括宫内外同时妊娠1例),异位妊娠发生率为7.9%.其中因输卵管病变发生异位妊娠21例(10.3%),非输卵管病变发生异位妊娠5例(3.97%).年龄、不孕类型及助孕方式与异位妊娠的发生无关.结论 异位妊娠的发生与输卵管病变有关,妊娠早期测定β-人绒毛膜促性腺激素(β-HCG)和行阴道超声监测,有利于异位妊娠的早期诊断和治疗.
目的 探討體外受精-胚胎移植後異位妊娠的髮生率、高危因素及診斷、預防.方法對我院2005年3月至2007年12月接受體外受精-胚胎移植(包括卵胞漿內單精子顯微註射)治療後的970箇移植週期的臨床資料進行迴顧性分析.結果 329例穫臨床妊娠,其中宮內妊娠303例,異位妊娠26例(包括宮內外同時妊娠1例),異位妊娠髮生率為7.9%.其中因輸卵管病變髮生異位妊娠21例(10.3%),非輸卵管病變髮生異位妊娠5例(3.97%).年齡、不孕類型及助孕方式與異位妊娠的髮生無關.結論 異位妊娠的髮生與輸卵管病變有關,妊娠早期測定β-人絨毛膜促性腺激素(β-HCG)和行陰道超聲鑑測,有利于異位妊娠的早期診斷和治療.
목적 탐토체외수정-배태이식후이위임신적발생솔、고위인소급진단、예방.방법대아원2005년3월지2007년12월접수체외수정-배태이식(포괄란포장내단정자현미주사)치료후적970개이식주기적림상자료진행회고성분석.결과 329례획림상임신,기중궁내임신303례,이위임신26례(포괄궁내외동시임신1례),이위임신발생솔위7.9%.기중인수란관병변발생이위임신21례(10.3%),비수란관병변발생이위임신5례(3.97%).년령、불잉류형급조잉방식여이위임신적발생무관.결론 이위임신적발생여수란관병변유관,임신조기측정β-인융모막촉성선격소(β-HCG)화행음도초성감측,유리우이위임신적조기진단화치료.
Objective To study the incidence, risk factors and clinical manifestation for ectopic pregnancy (EP) after in vitro fertilization and embryotransfer (IVF-ET). Methods A retrospective study of 970 embryo-transfer cycles about IVF and intracytoplasmic sperm injection (ICSI) was performed between March 2005 and December 2007. Results A total of 329 women conceived after IVF or ICSl were studied. The rate of EP was 7.9%,corresponding with 26 Eps,of which 1 was heterotopic pregnancy(HP).There were 21 Eps(10.3%)in tubal factor group,and 5(3.97%)in nontubal factor group.There appear to be no relationship between age, the type of infertility and the mode of assisted reproduction. Conclusion Tubal pathology is associated with increased risk of EP. Close hormonal β-HCG and ultrasonographic follow up in early pregnancies achieved in IVF treatments are recommended for early diagnosis and avoidance of further undesired consequences.